The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Abstract
An immunoradiometric assay (IRMA) has been used to determine circulating levels of the breast cancer-associated antigen, CA15-3. Of 1,050 normal control subjects, serum from 99 (9.4%) had CA15-3 antigen levels greater than 22 U/mL, while that from 58 (5.5%) and 14 (1.3%) had levels greater than 25 U/mL and 30 U/mL, respectively. In contrast, 115 of 158 patients (73%) with metastatic breast cancer had CA15-3 levels greater than 22 U/mL. Thirteen of 26 patients (50%) with only local metastases, 27 of 34 (79%) of those with only bone metastases, and 20 of 24 (83%) with hepatic metastases had CA15-3 levels greater than 22 U/mL. Furthermore, nine of 31 patients (29%) with primary breast cancer had CA15-3 levels greater than 22 U/mL. CA15-3 and carcinoembryonic antigen (CEA) levels were compared for the same patient population. Significantly more patients with metastatic breast cancer had elevated CA15-3 levels than had elevated CEA levels (P less than .001). Furthermore, the CA15-3 IRMA was more sensitive than the CEA assay in patients with only bone metastases, as well as those with only local metastases. Significantly more patients with primary carcinoma of the breast also had elevated CA15-3 than had elevated CEA levels (P less than .02). CA15-3 levels were greater than 22 U/mL in patients with nonmalignant conditions, including five of 25 patients (20%) with benign breast diseases, and 23 of 52 patients (44%) with benign liver diseases. Furthermore, CA15-3 levels were also greater than 22 U/mL in 24 of 54 patients (44%) with gastrointestinal (GI) malignancies, 12 of 17 patients (71%) with bronchogenic carcinoma, and 29 of 44 patients (66%) with epithelial ovarian carcinoma. Serial CA15-3 levels correlated with clinical disease course. Nineteen of 21 patients (91%) with tumor progression had at least a 25% increase in CA15-3 levels. Conversely, seven of nine patients (78%) with tumor regression had at least a 50% decrease in CA15-3 levels. Among 27 patients with stable disease, 16 (59%) had levels that did not vary by more than +/- 25% of the original CA15-3 levels. These results indicate that the CA15-3 antigen is a sensitive marker for the evaluation and monitoring of patients with breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of Ranks in One-Criterion Variance Analysis
Kruskal, W. H., & Wallis, W. A. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483441 · Cited by 13,912
KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.223 · Cited by 573
Self-citationHilkens, J., Buijs, F., Hilgers, J., Hageman, P., Calafat, J., Sonnenberg, A., & Van Vlak, M. D. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340210 · Cited by 488
Hayes, D. F., Sekine, H., Ohno, T., Abe, M., Keefe, K., & Kufe, D. W. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111875 · Cited by 210
Self-citationKloppel, T. Μ., Keenan, T. W., Freeman, M. J., & Morré, D. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3011 · Cited by 132
Circulating human mammary epithelial antigens in breast cancer.
Ceriani, R., Sasaki, M., Sussman, H. H., Wara, W. M., & Blank, E. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5420 · Cited by 112
Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA)
Thomas, P., & Zamcheck, N. (1983) · Digestive Diseases and Sciences · doi:10.1007/bf01295116 · Cited by 90
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine, H., Hayes, D. F., Ohno, T., Keefe, K. A., Schaetzl, E., Bast, R. C., KNAPP, R. C., & Kufe, D. W. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.10.1355 · Cited by 47
Self-citationDifferences between Proportions
Cohen, J. (2013) · doi:10.4324/9780203771587-12 · Cited by 21
Cited by
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Self-citationLigtenberg, M. J., Vos, H. L., Gennissen, A. M., & Hilkens, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39399-8 · Cited by 369
Metadata
- Authors
- Hayes, D. F., Zurawski, V. R., & Kufe, D. W.
- Venue
- Journal of Clinical Oncology
- Published
- 1986-10
- Volume
- 4
- Issue
- 10
- Pages
- 1542-1550
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1950887784
- Cited by
- 319
- References
- 9
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. https://app.cochat.ai/papers/10.1200/jco.1986.4.10.1542
- The paper
- Hayes, D. F., Zurawski, V. R., & Kufe, D. W. (1986). Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1986.4.10.1542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.